FUNDACION INCIENSA

EXTENSION OF ESCUDDO FOLLOW-UP FROM FIVE YEARS TO 7.5 YEARS (REFERRED TO AS ESCUDDO-7) WILL EVALUATE THE DURABILITY OF THE NON-INFERIORITY OF PROTECTION AFFORDED BY ONE VERSUS TWO DOSES OF THE HPV VACCINES.

EXERCISE AND FULLY FUND OPTION #8 AND UPDATE ARTICLES, B.3., F.1., G.4, AND SECTION J

EXTENSION OF ESCUDDO FOLLOW-UP FROM FIVE YEARS TO 7.5 YEARS (REFERRED TO AS ESCUDDO-7) WILL EVALUATE THE DURABILITY OF THE NON-INFERIORITY OF PROTECTION AFFORDED BY ONE VERSUS TWO DOSES OF THE HPV VACCINES.

PURPOSE OF MODIFICATION IS TO EXERCISE & FULLY FUND OPTION 2 IN THE AMOUNT OF $2,401,675; EXTEND THE TASK ORDER PERIOD OF PERFORMANCE THROUGH JANUARY 31, 2026 AND UPDATE ARTICLES B.2., F.1., AND G.4.

PURPOSE OF MODIFICATION 1)EXERCISE AND FULLY FUND OPTION 2; 2)DE-OBLIGATE FROM BASE, OPTIONS/OPTIONAL TASKS BOTH THE SAMPLE SIZE AND FUNDED AMOUNTS; 3)UPDATE ARTICLES B.2., F.1., G.4., AND H.2.

EXERCISE AND FULLY FUND OPTION #7 AND UPDATE ARTICLES, B.3., F.1., AND G.4

KICK-OFF OF EPIDEMIOLOGY AND PREVENTION OF INFECTIONS AND RELATED DISEASES IDIQ

PRISMA AND EXTEND 2.0 FOLLOW-UP OF STUDY PARTICIPANTS

FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS

LAB TESTING OF BIOSPECIMENS COLLECTED FROM PARTICIPANTS OF THE NCI'S HPV VACCINE STUDIES

PRISMA AND EXTEND 2.0 FOLLOW-UP OF STUDY PARTICIPANTS

LAB TESTING OF BIOSPECIMENS COLLECTED FROM PARTICIPANTS OF THE NCI'S HPV VACCINE STUDIES

FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL

FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS